180 Life Sciences Corp. (ATNF)
| Market Cap | 187.06M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -46.01M |
| Shares Out | 33.77M |
| EPS (ttm) | -2.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 897,930 |
| Open | 5.70 |
| Previous Close | 5.85 |
| Day's Range | 5.48 - 5.85 |
| 52-Week Range | 1.90 - 13.05 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About ATNF
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The comp...
Financial Performance
Financial StatementsNews
Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a Supply Agreement for the Ongo...
Three Anti-TNF Product Candidates To Be Included in Expected Global Agreement Three Anti-TNF Product Candidates To Be Included in Expected Global Agreement
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
PALO ALTO, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b clinical trial, fo...
180 Life Sciences Corp. Announces Closing of $15.0 Million Private Placement
PALO ALTO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the "Company"), a clinical-stage biotechnology company focused on the development of n...
Why 180 Life Sciences Stock Is Falling Today
Another capital raise less than a year after the company's stock market debut is more than a little troubling.
180 Life Sciences Corp. Announces $15.0 Million Private Placement
PALO ALTO, Calif., Aug. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of nov...
180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue
Collaboration Between the Pioneer of Cannabis Chemistry in Israel, Professor Raphi Mechoulam, Sir Marc Feldmann's Laboratory in Oxford, and 180 Life Sciences Scientists, Identifies a Non-Psychoactive Ca...
180 Life Science Corp Nears Key Levels And Could Breakout Soon
180 Life Sciences Corp (NASDAQ: ATNF) shares are trading higher Monday after the company announced it regained compliance with the Nasdaq. The company was notified Jan. 6 it did not meet the listing req...
180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2)
MENLO PARK, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of ...
180 Life Sciences Joins Russell Microcap® Index
MENLO PARK, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of ...
180 Life Sciences Files Plan with Nasdaq Related to Delayed Quarterly Report on Form 10-Q and Form 10-K
Company Granted Extension Until July 31, 2021, to Regain Compliance Company Granted Extension Until July 31, 2021, to Regain Compliance
180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Direc...
MENLO PARK, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of no...
180 Life Sciences Corp. to Present at LD Micro Invitational XI
Management to Present Thursday June 10th Management to Present Thursday June 10th
180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors
MENLO PARK, Calif., May 28, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of nov...
180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report on Form 10-Q
MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of n...
180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Annual Report on Form 10-K
MENLO PARK, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the "Company"), a clinical-stage biotechnology company focused on the development of...
180 Life Sciences Corp. Congratulates Dr. Lynn Williams on International Dupuytren Award 2021
Company actively pursuing Collagen VI pathway identified in peer-reviewed publication Company actively pursuing Collagen VI pathway identified in peer-reviewed publication
What's Happening With ATNF Stock And CELC Stock?
180 Life Sciences Corp (NASDAQ: ATNF) shares are trading higher following insider buying from Marc Feldmann, a director on the company's board, and Jonathan Rothbard, the company's chief scientific offi...
Why Ikena Oncology, Evelo Biosciences And 180 Life Sciences Are Rallying Today
Ikena Oncology, Inc. (NASDAQ: IKNA), 180 Life Sciences Corp. (NASDAQ: ATNF) and Evelo Biosciences, Inc. (NASDAQ: EVLO) are among the major biopharma movers of Monday. Ikena Oncology Gains On Fund Buying...
5 Reddit Penny Stocks Seeing the Most Chatter Friday
Reddit penny stocks continue to be a hot subject among retail investors and we're looking at the most-talked-about ones today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared firs...
180 Life Science Rallies 18%: Technical Levels To Watch
180 Life Sciences Corp. (NASDAQ: ATNF) shares rallied Friday, and there was no company evident news to explain the rise in shares. The stock closed up 18.5% at $6.96.
ATNF Stock: Why 180 Life Sciences Is Soaring Higher Today
ATNF stock is soaring today, as investors digest a recent intriguing podcast the company released highlighting its long-term plans. The post ATNF Stock: Why 180 Life Sciences Is Soaring Higher Today app...
180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics
NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF) announces the availability of a broadcast titled, “Controlling Inflammation to Stop Disease.”
180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters
NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — 180 Life Sciences Corp. (NASDAQ: ATNF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trus...